Your browser doesn't support javascript.
loading
A Rapid and Efficient Screening System for Neutralizing Antibodies and Its Application for SARS-CoV-2.
Han, Xiaojian; Wang, Yingming; Li, Shenglong; Hu, Chao; Li, Tingting; Gu, Chenjian; Wang, Kai; Shen, Meiying; Wang, Jianwei; Hu, Jie; Wu, Ruixin; Mu, Song; Gong, Fang; Chen, Qian; Gao, Fengxia; Huang, Jingjing; Long, Yingyi; Luo, Feiyang; Song, Shuyi; Long, Shunhua; Hao, Yanan; Li, Luo; Wu, Yang; Xu, Wei; Cai, Xia; Gao, Qingzhu; Zhang, Guiji; He, Changlong; Deng, Kun; Du, Li; Nai, Yaru; Wang, Wang; Xie, Youhua; Qu, Di; Huang, Ailong; Tang, Ni; Jin, Aishun.
Afiliación
  • Han X; Department of Immunology, College of Basic Medicine, Chongqing Medical University, Chongqing, China.
  • Wang Y; Chongqing Key Laboratory of Basic and Translational Research of Tumor Immunology, Chongqing Medical University, Chongqing, China.
  • Li S; Department of Immunology, College of Basic Medicine, Chongqing Medical University, Chongqing, China.
  • Hu C; Chongqing Key Laboratory of Basic and Translational Research of Tumor Immunology, Chongqing Medical University, Chongqing, China.
  • Li T; Department of Immunology, College of Basic Medicine, Chongqing Medical University, Chongqing, China.
  • Gu C; Chongqing Key Laboratory of Basic and Translational Research of Tumor Immunology, Chongqing Medical University, Chongqing, China.
  • Wang K; Department of Immunology, College of Basic Medicine, Chongqing Medical University, Chongqing, China.
  • Shen M; Chongqing Key Laboratory of Basic and Translational Research of Tumor Immunology, Chongqing Medical University, Chongqing, China.
  • Wang J; Department of Immunology, College of Basic Medicine, Chongqing Medical University, Chongqing, China.
  • Hu J; Chongqing Key Laboratory of Basic and Translational Research of Tumor Immunology, Chongqing Medical University, Chongqing, China.
  • Wu R; Key Laboratory of Medical Molecular Virology, Department of Medical Microbiology and Parasitology, School of Basic Medical Sciences, Shanghai Medical College, Fudan University, Shanghai, China.
  • Mu S; Key Laboratory of Molecular Biology on Infectious Diseases, Ministry of Education, Chongqing Medical University, Chongqing, China.
  • Gong F; Department of Breast Surgery, Harbin Medical University Cancer Hospital, Harbin, China.
  • Chen Q; Department of Immunology, College of Basic Medicine, Chongqing Medical University, Chongqing, China.
  • Gao F; Chongqing Key Laboratory of Basic and Translational Research of Tumor Immunology, Chongqing Medical University, Chongqing, China.
  • Huang J; Key Laboratory of Molecular Biology on Infectious Diseases, Ministry of Education, Chongqing Medical University, Chongqing, China.
  • Long Y; Department of Immunology, College of Basic Medicine, Chongqing Medical University, Chongqing, China.
  • Luo F; Chongqing Key Laboratory of Basic and Translational Research of Tumor Immunology, Chongqing Medical University, Chongqing, China.
  • Song S; Department of Immunology, College of Basic Medicine, Chongqing Medical University, Chongqing, China.
  • Long S; Chongqing Key Laboratory of Basic and Translational Research of Tumor Immunology, Chongqing Medical University, Chongqing, China.
  • Hao Y; Department of Pediatrics, Yongchuan Hospital Affiliated to Chongqing Medical University, Chongqing, China.
  • Li L; Department of Immunology, College of Basic Medicine, Chongqing Medical University, Chongqing, China.
  • Wu Y; Chongqing Key Laboratory of Basic and Translational Research of Tumor Immunology, Chongqing Medical University, Chongqing, China.
  • Xu W; Department of Immunology, College of Basic Medicine, Chongqing Medical University, Chongqing, China.
  • Cai X; Chongqing Key Laboratory of Basic and Translational Research of Tumor Immunology, Chongqing Medical University, Chongqing, China.
  • Gao Q; Department of Immunology, College of Basic Medicine, Chongqing Medical University, Chongqing, China.
  • Zhang G; Chongqing Key Laboratory of Basic and Translational Research of Tumor Immunology, Chongqing Medical University, Chongqing, China.
  • He C; Department of Immunology, College of Basic Medicine, Chongqing Medical University, Chongqing, China.
  • Deng K; Chongqing Key Laboratory of Basic and Translational Research of Tumor Immunology, Chongqing Medical University, Chongqing, China.
  • Du L; Department of Immunology, College of Basic Medicine, Chongqing Medical University, Chongqing, China.
  • Nai Y; Chongqing Key Laboratory of Basic and Translational Research of Tumor Immunology, Chongqing Medical University, Chongqing, China.
  • Wang W; Department of Immunology, College of Basic Medicine, Chongqing Medical University, Chongqing, China.
  • Xie Y; Chongqing Key Laboratory of Basic and Translational Research of Tumor Immunology, Chongqing Medical University, Chongqing, China.
  • Qu D; Department of Immunology, College of Basic Medicine, Chongqing Medical University, Chongqing, China.
  • Huang A; Chongqing Key Laboratory of Basic and Translational Research of Tumor Immunology, Chongqing Medical University, Chongqing, China.
  • Tang N; Department of Immunology, College of Basic Medicine, Chongqing Medical University, Chongqing, China.
  • Jin A; Chongqing Key Laboratory of Basic and Translational Research of Tumor Immunology, Chongqing Medical University, Chongqing, China.
Front Immunol ; 12: 653189, 2021.
Article en En | MEDLINE | ID: mdl-33828563
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Anticuerpos Neutralizantes / SARS-CoV-2 / COVID-19 / Anticuerpos Antivirales Tipo de estudio: Diagnostic_studies / Screening_studies Límite: Humans Idioma: En Revista: Front Immunol Año: 2021 Tipo del documento: Article País de afiliación: China Pais de publicación: Suiza
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Anticuerpos Neutralizantes / SARS-CoV-2 / COVID-19 / Anticuerpos Antivirales Tipo de estudio: Diagnostic_studies / Screening_studies Límite: Humans Idioma: En Revista: Front Immunol Año: 2021 Tipo del documento: Article País de afiliación: China Pais de publicación: Suiza